{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:14:31Z","timestamp":1795029271267,"version":"4.10.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The BioFire\u00ae FilmArray\u00ae Blood Culture Identification Panel 1 (BF-FA-BCIP) detects microorganisms with high accuracy in positive blood cultures (BC) \u2013 a key step in the management of patients with suspected bacteraemia. We aimed to compare the time to optimal antimicrobial therapy (OAT) for the BF-FA-BCIP vs. standard culture-based identification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-centre study with a before-after design, 386 positive BC cases with identification by BF-FA-BCIP were compared to 414 controls with culture-based identification. The primary endpoint was the time from BC sampling to OAT. Secondary endpoints were time to effective therapy, length of stay, (re-)admission to ICU, in-hospital and 30-day mortality. Outcomes were assessed using Cox proportional hazard models and logistic regressions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline characteristics of included adult inpatients were comparable. Main sources of bacteraemia were urinary tract and intra-abdominal infection (19.2% vs. 22.0% and 16.8% vs. 15.7%, for cases and controls, respectively). Median (95%CI) time to OAT was 25.5 (21.0\u201331.2) hours with BF-FA-BCIP compared to 45.7 (37.7\u201351.4) hours with culture-based identification. We observed no significant difference for secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Rapid microorganism identification by BF-FA-BCIP was associated with a median 20-h earlier initiation of OAT in patients with positive BC. No impact on length of stay and mortality was noted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Clinicaltrials.gov, NCT04156633, registered on November 5, 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08732-9","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:02:24Z","timestamp":1698300144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy \u2013 a before-after study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jessica","family":"Agnetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Osthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Helfenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Siegemund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Bingisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Clauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimira","family":"Hinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tschudin-Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"B\u00e4ttig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Egli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"issue":"6","key":"8732_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"8732_CR2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"issue":"5","key":"8732_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15(5):581\u2013614.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"8732_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernandez-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32\u201340.","journal-title":"Intensive Care Med"},{"issue":"2","key":"8732_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159\u201377.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8732_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cid\/ciw649","volume":"64","author":"TT Timbrook","year":"2017","unstructured":"Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis. 2017;64(1):15\u201323.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"8732_CR7","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/JCM.00996-16","volume":"54","author":"SH MacVane","year":"2016","unstructured":"MacVane SH, Nolte FS. Benefits of adding a rapid PCR-Based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol. 2016;54(10):2455\u201363.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"8732_CR8","doi-asserted-by":"publisher","first-page":"e0223122","DOI":"10.1371\/journal.pone.0223122","volume":"14","author":"A Verroken","year":"2019","unstructured":"Verroken A, Despas N, Rodriguez-Villalobos H, Laterre PF. The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: a pre-post intervention study. PLoS One. 2019;14(9):e0223122.","journal-title":"PLoS One"},{"issue":"10","key":"8732_CR9","doi-asserted-by":"publisher","first-page":"ofy258","DOI":"10.1093\/ofid\/ofy258","volume":"5","author":"BA Buss","year":"2018","unstructured":"Buss BA, Baures TJ, Yoo M, Hanson KE, Alexander DP, Benefield RJ, et al. Impact of a Multiplex PCR Assay for Bloodstream Infections With and Without Antimicrobial Stewardship Intervention at a Cancer Hospital. Open Forum Infect Dis. 2018;5(10):ofy258.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"8732_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.diagmicrobio.2015.10.023","volume":"84","author":"J Pardo","year":"2016","unstructured":"Pardo J, Klinker KP, Borgert SJ, Butler BM, Giglio PG, Rand KH. Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis. 2016;84(2):159\u201364.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"8732_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/cid\/civ447","volume":"61","author":"R Banerjee","year":"2015","unstructured":"Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61(7):1071\u201380.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"8732_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1373\/jalm.2018.027409","volume":"3","author":"RC She","year":"2019","unstructured":"She RC, Bender JM. Advances in rapid molecular blood culture diagnostics: healthcare impact, laboratory implications, and multiplex technologies. J Appl Lab Med. 2019;3(4):617\u201330.","journal-title":"J Appl Lab Med"},{"issue":"2","key":"8732_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmi.2016.08.009","volume":"23","author":"M Osthoff","year":"2017","unstructured":"Osthoff M, Gurtler N, Bassetti S, Balestra G, Marsch S, Pargger H, et al. Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial. Clin Microbiol Infect. 2017;23(2):78\u201385.","journal-title":"Clin Microbiol Infect"},{"key":"8732_CR14","unstructured":"Centers for Disease Control and Prevention. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection) 2022. Available from: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/4psc_clabscurrent.pdf. Accessed 23.10.2022."},{"issue":"4","key":"8732_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1128\/CMR.00062-05","volume":"19","author":"KK Hall","year":"2006","unstructured":"Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev. 2006;19(4):788\u2013802.","journal-title":"Clin Microbiol Rev"},{"key":"8732_CR16","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 8.0, 2018. http:\/\/www.eucast.org."},{"key":"8732_CR17","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 9.0, 2019. http:\/\/www.eucast.org."},{"key":"8732_CR18","volume-title":"Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute. 28th ed. Wayne: CLSI supplement M100. Clinical and Laboratory Standards Institute; 2018.","edition":"28"},{"key":"8732_CR19","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2019","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 29th ed. Wayne: CLSI supplement M100. Clinical and Laboratory Standards Institute; 2019.","edition":"29"},{"issue":"8","key":"8732_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"11","key":"8732_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"8732_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"446","key":"8732_CR23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"8732_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2307\/3315916","volume":"28","author":"H Blaker","year":"2000","unstructured":"Blaker H. Confidence curves and improved exact confidence intervals for discrete distributions. Can J Stat. 2000;28(4):783\u201398.","journal-title":"Can J Stat"},{"issue":"11","key":"8732_CR25","doi-asserted-by":"publisher","first-page":"e00843","DOI":"10.1128\/JCM.00843-18","volume":"56","author":"AG Dinkelacker","year":"2018","unstructured":"Dinkelacker AG, Vogt S, Oberhettinger P, Mauder N, Rau J, Kostrzewa M, et al. Typing and Species Identification of Clinical Klebsiella Isolates by Fourier Transform Infrared Spectroscopy and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol. 2018;56(11):e00843-18.","journal-title":"J Clin Microbiol"},{"issue":"24","key":"8732_CR26","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.3390\/jcm10245880","volume":"10","author":"J Schumann","year":"2021","unstructured":"Schumann J, Johanns U, Ahmad-Nejad P, Ghebremedhin B, Woebker G. The impact of the FilmArray -based detection of microbial pathogens from positive blood culture vials on the time to optimal antimicrobial regimen in intensive care units of the Helios University Clinic Wuppertal, Germany. J Clin Med. 2021;10(24):5880.","journal-title":"J Clin Med."},{"issue":"3","key":"8732_CR27","first-page":"267","volume":"6","author":"K Messacar","year":"2017","unstructured":"Messacar K, Hurst AL, Child J, Campbell K, Palmer C, Hamilton S, et al. Clinical impact and provider acceptability of real-time antimicrobial stewardship decision support for rapid diagnostics in children with positive blood culture results. J Pediatric Infect Dis Soc. 2017;6(3):267\u201374.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"10","key":"8732_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1080\/23744235.2016.1185533","volume":"48","author":"SH MacVane","year":"2016","unstructured":"MacVane SH, Hurst JM, Boger MS, Gnann JW Jr. Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia. Infect Dis (Lond). 2016;48(10):732\u20137.","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"8732_CR29","doi-asserted-by":"publisher","first-page":"e00095","DOI":"10.1128\/CMR.00095-17","volume":"31","author":"EE Pliakos","year":"2018","unstructured":"Pliakos EE, Andreatos N, Shehadeh F, Ziakas PD, Mylonakis E. The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship. Clin Microbiol Rev. 2018;31(3):e00095-17.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"8732_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/jac\/dkab398","volume":"77","author":"K Mponponsuo","year":"2022","unstructured":"Mponponsuo K, Leal J, Spackman E, Somayaji R, Gregson D, Rennert-May E. Mathematical model of the cost-effectiveness of the BioFire FilmArray Blood Culture Identification (BCID) Panel molecular rapid diagnostic test compared with conventional methods for identification of Escherichia coli bloodstream infections. J Antimicrob Chemother. 2022;77(2):507\u201316.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"8732_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","volume":"23","author":"OJ Dyar","year":"2017","unstructured":"Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"8732_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/14787210.2016.1233814","volume":"14","author":"E Minejima","year":"2016","unstructured":"Minejima E, Wong-Beringer A. Implementation of rapid diagnostics with antimicrobial stewardship. Expert Rev Anti Infect Ther. 2016;14(11):1065\u201375.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"8732_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijid.2019.11.028","volume":"91","author":"R Nasef","year":"2020","unstructured":"Nasef R, El Lababidi R, Alatoom A, Krishnaprasad S, Bonilla F. The Impact of Integrating Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program in the United Arab of Emirates. Int J Infect Dis. 2020;91:124\u20138.","journal-title":"Int J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08732-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:02:51Z","timestamp":1698300171000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08732-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8732"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08732-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"21 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the Declaration of Helsinki and relevant guidelines and regulations. The study protocol was approved by the Ethics Committee of Northwest and Central Switzerland (Ethikkommission Nordwest- und Zentralschweiz (EKNZ), Project-ID 2019\u201301860). The need for written informed consent was waived by the Ethics Committee of Northwest and Central Switzerland (Ethikkommission Nordwest- und Zentralschweiz (EKNZ)) due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"730"}}